MedTrace Logo

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

NCT06745297 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2025-11-21

No results posted yet for this study

Summary

The trial aims to study the safety, tolerability, and pharmacokinetics of single and multiple rising doses of BI 3776528.

Conditions

  • Healthy

Interventions

DRUG

BI 3776528

BI 3776528

DRUG

Placebo matching BI 3776528

Placebo matching BI 3776528

DRUG

short-acting benzodiazepine

short-acting benzodiazepine

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-23
Primary Completion
2026-08-25
Completion
2026-08-25

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745297 on ClinicalTrials.gov